Price movement over the last 24 hours
iShares MSCI ACWI ETF vs Viatris Inc — how do they compare? iShares MSCI ACWI ETF trades at $155.9, while Viatris Inc trades at $16.63 (market cap $19.75B). The key difference: Viatris Inc pays a 2.83% dividend while iShares MSCI ACWI ETF pays none. Which is the better fit depends on your goals.
| ACWI | VTRS | |
|---|---|---|
52-Week High | $159.97 | $17.39 |
52-Week Low | $128.32 | $8.74 |
Market Cap | — | $19.75B |
Sector | — | Health |
Enterprise Value | — | $31.96B |
Dividend Yield | — | 2.83% |
Trailing returns across standard periods
Latest headlines on both assets
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →